Prolia 60 MG/ML syringeml
Ended Awarded Last action
- Contract number
- SPE2DR26F4F9Z
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $38,241
Award facts
- Contract value 100% obligated
- $38,240.52 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $38,240.52 to AmerisourceBergen Drug Corp for the supply of Prolia 60 mg/ml syringes, with an ultimate completion date of January 29, 2026. This is a firm fixed-price, non-set-aside contract awarded on January 28, 2026, with performance taking place at the contractor's facility in Conshohocken, Pennsylvania. Prolia is a monoclonal antibody used to treat osteoporosis and related bone conditions, making this procurement part of the Defense Health Agency's pharmaceutical supply needs for military treatment facilities and beneficiaries.
This delivery order is issued under AmerisourceBergen's parent company Cencora, Inc.'s larger Indefinite Delivery Contract with DLA Troop Support Medical, valued at up to $999,999,999.00 through December 31, 2031. This comprehensive IDC serves as the primary vehicle for supplying a broad range of pharmaceutical products and medical supplies to support military healthcare programs globally. AmerisourceBergen, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, has demonstrated its capability to fulfill federal procurement requirements through open competition, consistently delivering specialty medications, brand-name and generic drugs, and medical supplies across multiple therapeutic domains to support military and veteran healthcare systems.
Quick answers
Who was awarded contract SPE2DR26F4F9Z?
SPE2DR26F4F9Z was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 28, 2026.
How much is contract SPE2DR26F4F9Z worth?
The government has obligated $38,241 on SPE2DR26F4F9Z.
Is contract SPE2DR26F4F9Z an order under another contract?
Yes. SPE2DR26F4F9Z is a delivery order under SPE2DR25D3012, an indefinite delivery contract.
Was contract SPE2DR26F4F9Z competed?
The extent of competition for SPE2DR26F4F9Z was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award